What is the maximum recommended dose of Mucinex (guaifenesin) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Mucinex (Guaifenesin)

For adults and children 12 years and older, the maximum dose of Mucinex extended-release is 2400 mg per day (four 600 mg tablets), with dosing of 1-2 tablets every 12 hours. 1

Adult Dosing

  • Standard dose: 1-2 extended-release tablets (600-1200 mg) every 12 hours
  • Maximum daily dose: 4 extended-release tablets (2400 mg) in 24 hours
  • Take with a full glass of water
  • Can be administered without regard to meals 1

Important: Do not crush, chew, or break the extended-release tablets, as this will disrupt the 12-hour release mechanism 1.

Pediatric Dosing

Children under 12 years of age should not use Mucinex extended-release tablets 1. The FDA labeling specifically excludes this age group from using the extended-release formulation.

Formulation Details

The extended-release formulation contains 600 mg guaifenesin per tablet 1 and uses a bi-layer technology that provides both immediate and extended release over 12 hours 1. This allows for twice-daily dosing compared to immediate-release formulations that require dosing every 4 hours 2.

Clinical Context

The extended-release formulation was developed specifically to reduce dosing frequency while maintaining therapeutic efficacy. Pharmacokinetic studies demonstrate that 1200 mg every 12 hours of extended-release guaifenesin provides equivalent steady-state exposure to 400 mg every 4 hours of immediate-release formulations 2. The dosing range of 1200-2400 mg daily allows for flexible titration based on symptom severity 3.

Safety Profile

Guaifenesin has a well-established safety profile in adults. In post-marketing surveillance of 552 patients taking 1200 mg every 12 hours for 7 days, only 5% experienced treatment-related adverse events, all mild in severity, with no serious adverse events reported 4. The most common side effects were gastrointestinal and nervous system related 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.